FIELD: medicine; pharmaceutics.
SUBSTANCE: invention concerns a pharmaceutical composition for preparation of a medical product for treatment of hypertonia bound to disturbance of metabolism, including moxonidine or its pharmaceutically comprehensible salt and eprosartan or its pharmaceutically comprehensible salt.
EFFECT: implication of synergistic action.
23 cl, 2 dwg, 3 tbl, 3 ex
Authors
Dates
2009-07-27—Published
2004-10-07—Filed